Relational world of chronic pain patients in the course of an inpatient multimodal pain treatment focusing on psychosomatic interventions

Conditions: Chronic pain
F45.41
F45.40

Registration Number: DRKS00010256

Lead Sponsor: niversitätsklinik für Psychosomatische Medizin und Psychotherapie, Ulm

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: All

Target Recruitment: 35

Inclusion Criteria

Diagnosis of F45.41 or F45.40, having had a consultation in the outpatient unit and having taken part in the information group before deciding to take part in the treatment program.

Exclusion Criteria

not taking part in the treatment program

Study & Design

Study Type: observational

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Dimensions of interoception: interoceptive accuracy, interoceptive sensibility and interoceptive awareness, as well as autonomous processes measured as (change in) vagal activity (via heart rate variability, HRV) (measured only in T1, T2, T3, T5). HRV and interoceptive accuracy are assessed via ECG with electrodes on the upper body (BIOPAC enhancer). This definitely is a non-invasive procedure. Interoceptive sensibility and awareness are assessed via body perception questionnaire (self-report).<br>Timetable measures:<br>T0-baseline, T1 start of the 5-week intervention, T2 2 weeks after start of the 5-week intervention, T3 end of 5-week intervention, T4 3 month after end of intervention, T5 12 month after end of intervention.

Secondary Outcome Measures

Name	Time	Method
All measures are assessed via self-reported questionnaires.<br>Assessment baseline/T0: Pain history, utilisation (items adapted from the German Pain Questionnaire) and childhood trauma (Childhood Trauma Questionnaire).<br>Assessment all measuring times T0-T5:<br>Quality of life (SF-12), pain intensity and frequency (items adapted from the German Pain Questionnaire), clinical mental health (PHQ-9,-15-,-7).<br>Assessment T1, T3, T4, T5:<br>Empathie (Levels of emotional awareness scale & Empathy Quotient , Progredienzangst).<br><br>During the 5-week intervention quality of therapeutic relationships within small groups will be assessed weekly as process variable with the Group Questionnaire (GQ-D).